Ultra Market Research | United Kingdom Multiple Myeloma Treatment Market
United Kingdom Multiple Myeloma Treatment Market
Report ID : 1064
Category : United-Kingdom(UK)
No Of Pages : 156
Published on: March 2025
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
United Kingdom Multiple Myeloma Treatment Market
Introduction
The United Kingdom Multiple Myeloma Treatment Market is the medical and pharmaceutical sector dedicated to the treatment of multiple myeloma, a cancer that occurs in plasma cells in the bone marrow. The patient outcomes have been greatly enhanced by recent developments in treatments, with new drugs being launched on a regular basis. The market is mainly influenced by rising awareness, research advancements, and an aging population. The market has a variety of treatments, from chemotherapy and stem cell transplantation to newer targeted therapies and immunotherapies. Immunotherapy, such as CAR T-cell therapy and monoclonal antibodies, has picked up momentum in the last few years, echoing the trend in the market toward more effective and personalized treatments. To date, the size of the market in the United Kingdom is still increasing as a result of the increasing incidence of the disease, as well as increased investment in research and development by drug companies.
Segmentation
Segment 1: Treatment Type
Chemotherapy
Chemotherapeutic Agents
Combination Therapy
Others
Stem Cell Transplantation
Autologous Stem Cell Transplant
Allogeneic Stem Cell Transplant
Others
Targeted Therapy
Proteasome Inhibitors
Immunomodulatory Drugs
Others
Immunotherapy
Monoclonal Antibodies
CAR T-cell Therapy
Others
Others
Segment 2: End User
Hospitals
Oncology Departments
Bone Marrow Transplant Centers
Others
Clinics
Private Clinics
Specialized Cancer Clinics
Others
Others
Segment 3: Route of Administration
Oral
Oral Chemotherapy Agents
Oral Targeted Therapy
Others
Intravenous
IV Chemotherapy
IV Immunotherapy
Others
Others
Segment 4: Distribution Channel
Hospital Pharmacies
Oncology Hospitals
General Hospitals
Retail Pharmacies
Independent Pharmacies
Chain Pharmacies
Online Pharmacies
E-commerce Platforms
Others
List of Market Players
Bristol-Myers Squibb (United States)
Novartis International AG (Switzerland)
Janssen Pharmaceuticals (United States)
Amgen Inc. (United States)
Takeda Pharmaceutical Company Limited (Japan)
Sanofi S.A. (France)
Merck & Co., Inc. (United States)
GlaxoSmithKline PLC (United Kingdom)
AbbVie Inc. (United States)
Roche Holding AG (Switzerland)
Celgene Corporation (United States)
AstraZeneca PLC (United Kingdom)
Eli Lilly and Company (United States)
Gilead Sciences, Inc. (United States)
Teva Pharmaceutical Industries Ltd. (Israel)
Drivers
The United Kingdom Multiple Myeloma Treatment Market is dominated by various factors. The first one is the rising prevalence of multiple myeloma, particularly in the elderly, boosting demand for therapy. As longevity increases, there are more individuals being diagnosed with the disease, thus demanding the need for treatments. Second, increases in medical research and the availability of new drugs like immunotherapy and CAR T-cell therapy have greatly enhanced the outcomes of patients, driving further market growth. Third, enhanced awareness of multiple myeloma among physicians and patients stimulates early diagnosis, thereby improving treatment outcomes. Also contributing to the upward growth of the market are enhanced healthcare spending, improved healthcare facilities, and growing government funding for cancer research.
Restraints
Although it has an optimistic forecast, the United Kingdom Multiple Myeloma Treatment Market is subject to some challenges. The expensive nature of novel and innovative therapies like CAR T-cell therapy and monoclonal antibodies can make it difficult for access by some patients, particularly those with limited insurance coverage. Further, the sophistication of treatment protocols like stem cell transplants has the potential to cause complications as well as logistic issues. In addition, there are regulatory barriers within drug approval procedures that can delay the launch of new treatments onto the market. The market also has intense competition from other cancer therapies, which can limit the growth potential of multiple myeloma drugs.
Opportunity
The market has a number of opportunities for expansion. The growing emphasis on personalized medicine, such as targeted therapies and genetic-based therapies, is an excellent opportunity to improve the efficacy of multiple myeloma treatment. The growing incidence of the disease, combined with advances in early detection technologies, generates the need for new, sophisticated treatment alternatives. In addition, the growing application of digital health technologies in tracking patients' improvement provides new opportunities for distant management of multiple myeloma. Finally, the possibilities of growth in emerging markets and rising investments in research and development by pharmaceutical giants will keep driving market growth.
Trend
One of the main trends in the United Kingdom Multiple Myeloma Treatment Market is the increase in immunotherapy. Immunotherapies such as CAR T-cell therapy, where the patient's immune system is used to destroy cancer cells, are gaining prominence. The trend toward immunotherapy is influenced by the fact that it provides very targeted and efficient treatments with lesser side effects than chemotherapy. Another growing trend is the use of combination therapies, wherein the patient undergoes several treatments simultaneously in order to achieve better patient outcomes. With ongoing research yielding new medicines and treatment regimens, the use of personalized and precision medicine is also gaining momentum. The trend is also moving towards digitalization with the application of AI and machine learning for the creation of new drugs as well as for monitoring the health of patients.
United Kingdom Multiple Myeloma Treatment Market by Patient Demographics 6.1 Introduction 6.2 Market Size and Growth Rate by Patient Demographics (2024-2030) 6.2.1 Children 6.2.1.1 Infants 6.2.1.2 Toddlers and Young Children 6.2.2 Adults 6.2.2.1 Young Adults 6.2.2.2 Seniors
United Kingdom Multiple Myeloma Treatment Market by Distribution Channels 7.1 Introduction 7.2 Market Size and Growth Rate by Distribution Channels (2024-2030) 7.2.1 Hospital Pharmacies 7.2.1.1 Tertiary Care Centers 7.2.1.2 Pediatric Oncology Units 7.2.2 Retail Pharmacies 7.2.2.1 Local Pharmacies 7.2.2.2 Chain Pharmacies 7.2.3 Online Pharmacies
United Kingdom Multiple Myeloma Treatment Market by Therapeutic Applications 8.1 Introduction 8.2 Market Size and Growth Rate by Therapeutic Applications (2024-2030) 8.2.1 First-Line Treatment 8.2.1.1 Chemotherapy-Only Regimens 8.2.1.2 Targeted Therapies 8.2.2 Relapse or Refractory Multiple Myeloma 8.2.2.1 CAR-T Therapies 8.2.2.2 Experimental Treatments
Appendix 11.1 List of Tables • Table United Kingdom Multiple Myeloma Treatment Market Size by Treatment Types (2024-2030) • Table Chemotherapy Market Size by Sub-type (2024-2030) • Table Targeted Therapies Market Size by Sub-type (2024-2030) • Table Immunotherapies Market Size by Sub-type (2024-2030) • Table United Kingdom Multiple Myeloma Treatment Market Size by Patient Demographics (2024-2030) • Table Children Market Size by Sub-type (2024-2030) • Table Adults Market Size by Sub-type (2024-2030) • Table United Kingdom Multiple Myeloma Treatment Market Size by Distribution Channels (2024-2030) • Table Hospital Pharmacies Market Size by Sub-type (2024-2030) • Table Retail Pharmacies Market Size by Sub-type (2024-2030) • Table United Kingdom Multiple Myeloma Treatment Market Size by Therapeutic Applications (2024-2030) • Table First-Line Treatment Market Size by Sub-type (2024-2030) • Table Relapse or Refractory Multiple Myeloma Market Size by Sub-type (2024-2030) 11.2 List of Figures • Figure United Kingdom Multiple Myeloma Treatment Market Size and Growth Rate by Treatment Types (2024-2030) • Figure Chemotherapy Market Growth Rate by Sub-type (2024-2030) • Figure Targeted Therapies Market Growth Rate by Sub-type (2024-2030) • Figure Immunotherapies Market Growth Rate by Sub-type (2024-2030) • Figure United Kingdom Multiple Myeloma Treatment Market Size and Growth Rate by Patient Demographics (2024-2030) • Figure Children Market Growth Rate by Sub-type (2024-2030) • Figure Adults Market Growth Rate by Sub-type (2024-2030) • Figure United Kingdom Multiple Myeloma Treatment Market Size and Growth Rate by Distribution Channels (2024-2030) • Figure Hospital Pharmacies Market Growth Rate by Sub-type (2024-2030) • Figure Retail Pharmacies Market Growth Rate by Sub-type (2024-2030) • Figure United Kingdom Multiple Myeloma Treatment Market Size and Growth Rate by Therapeutic Applications (2024-2030)
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of United States market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of United Kingdom Multiple Myeloma Treatment Marketand its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of United Kingdom Multiple Myeloma Treatment Marketfor the past year and forecasts for the next six years. United Kingdom Multiple Myeloma Treatment Marketsize is given in terms of revenue Market revenue is defined in USD Million. Market numbers are given on the basis of different United Kingdom Multiple Myeloma Treatment Marketcategories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for United Kingdom Multiple Myeloma Treatment Marketfrom different application industries in different regions.
